{"id":72614,"date":"2024-07-03T15:44:29","date_gmt":"2024-07-03T20:44:29","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/remuneration-2023-24\/"},"modified":"2025-07-23T14:50:54","modified_gmt":"2025-07-23T19:50:54","slug":"remuneration-2023-24","status":"publish","type":"page","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/","title":{"rendered":"R\u00e9mun\u00e9ration"},"content":{"rendered":"<p><strong>1.<\/strong> Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u202f022\u202f776\u202f$ pour l\u2019exercice clos le 31\u202fd\u00e9cembre\u202f2023.<\/p>\n<p><strong>2.<\/strong> Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31\u202fmars\u202f2024 \u00e9tait de 138. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge de travail.<\/p>\n<p><strong>3.<\/strong> Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du personnel suivants pour l\u2019exercice clos le 31\u202fd\u00e9cembre\u202f2023 (tel que d\u00e9clar\u00e9 sur les feuillets\u202fT4 pour 2023)\u202f:<\/p>\n<table class=\"table table-bordered\">\n<thead>\n<tr class=\"active\">\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>Titre<\/strong><\/th>\n<th style=\"vertical-align: top;\" width=\"33%\">R\u00e9mun\u00e9ration (feuillets\u202fT4 pour 2023)<\/th>\n<th style=\"vertical-align: top;\" width=\"33%\">Avantages imposables (inclus dans le montant de la r\u00e9mun\u00e9ration)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Pr\u00e9sident-directeur g\u00e9n\u00e9ral<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">$703 973,13<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">$5 238,83<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Syst\u00e8mes de lutte contre le cancer et innovation (anciennement Vice-pr\u00e9sidente, Lutte contre le cancer)<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">$269 743,59<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">$3 651,51<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sident, Syst\u00e8mes de lutte contre le cancer, rendement et innovation<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">$184 943,61<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">$3 265,67<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sident, Finances et services de l\u2019entreprise<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">$294 985,49<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">$4 788,19<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Partenariats strat\u00e9giques<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">279 210,89 $<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">$4 788,19<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em><small>*En 2023, la division de Lutte contre le cancer et la division des Syst\u00e8mes de lutte contre le cancer, du rendement et de l\u2019innovation ont fusionn\u00e9 pour former la division des Syst\u00e8mes de lutte contre le cancer et de l\u2019innovation.<\/small><\/em><\/p>\n<p><strong>4.<\/strong> Fourchettes salariales des membres du personnel du Partenariat (en vigueur \u00e0 compter du 31\u202fmars\u202f2024)\u202f:<\/p>\n<table class=\"table table-bordered\">\n<tbody>\n<tr class=\"active\">\n<th style=\"vertical-align: top;\" width=\"10%\">Niveau<\/th>\n<th style=\"vertical-align: top;\" width=\"40%\">Poste<\/th>\n<th style=\"vertical-align: top;\" width=\"40%\">Fourchette de r\u00e9mun\u00e9ration annuelle<\/th>\n<th style=\"vertical-align: top;\" width=\"10%\"><strong>Nombre de membres du personnel permanents \u00e0 temps plein <\/strong><\/th>\n<\/tr>\n<\/tbody>\n<tbody>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">9<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Directrice\/directeur<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">131 895\u202f$ \u00e0 202\u202f753\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">15<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">8<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Responsable r\u00e9gionale\/r\u00e9gional<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">120\u202f936\u202f$ \u00e0 166\u202f466\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">1<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">7<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Gestionnaire, partenaire principal\/principale d\u2019affaires en RH, gestionnaire de programme, contr\u00f4leuse\/contr\u00f4leur de gestion, responsable, architecte d\u2019entreprise<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">100\u202f780\u202f$ \u00e0 138\u202f721\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">32<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">6<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, gestionnaire de programme, gestionnaire de service, responsable, sp\u00e9cialiste, conseill\u00e8re\/conseiller, comptable principal\/principale, d\u00e9veloppeuse\/d\u00e9veloppeur Web, gestionnaire de projet<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">80\u202f624\u202f$ \u00e0 109\u202f080\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">55<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">5<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, agente\/agent, adjointe\/adjoint de direction au pr\u00e9sident-directeur g\u00e9n\u00e9ral<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">70\u202f723\u202f$ \u00e0 95\u202f683\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">11<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">4b<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Adjointe principale\/adjoint principal de direction<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">62\u202f037\u202f$ \u00e0 83\u202f933\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">2<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">4<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Coordonnatrice\/coordonnateur<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">54\u202f419\u202f$ \u00e0 73\u202f626\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">12<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">3<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Adjointe administrative\/adjoint administratif<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">47\u202f736\u202f$ \u00e0 64\u202f584\u202f$<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">6<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\"><\/td>\n<td style=\"vertical-align: top;\" width=\"264\"><\/td>\n<td style=\"vertical-align: top;\" width=\"144\"><strong>TOTAL<\/strong><\/td>\n<td style=\"vertical-align: top;\" width=\"118\"><strong>138*<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em><small>*\u202fComprends 134\u202femploy\u00e9s et 4\u202fmembres de la haute direction\u00a0<\/small><\/em><\/p>\n<p><strong>5.<\/strong> Le montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du conseil d\u2019administration du Partenariat pour l\u2019exercice clos le 31\u202fd\u00e9cembre\u202f2023 (tel que d\u00e9clar\u00e9 \u00e0 l\u2019Agence du revenu du Canada sur les feuillets\u202fT4 pour 2023) s\u2019\u00e9levait \u00e0 133\u202f083\u202f$.<\/p>\n<h3>R\u00e9mun\u00e9ration du Partenariat<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2022-23\/\">R\u00e9mun\u00e9ration 2022-2023<\/a><\/li>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/\">R\u00e9mun\u00e9ration 2021-2022<\/a><\/li>\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2021\/07\/Salary_Disclosure_2020-2021_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2020-2021<\/a><\/li>\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2020\/08\/Compensation-FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2019-2020<\/a><\/li>\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2019\/07\/Disclosure_Document_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2018-2019<\/a><\/li>\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2018\/08\/Salaries-and-Disclosure_Fre_Final.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2017-2018<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u202f022\u202f776\u202f$ pour l\u2019exercice clos le 31\u202fd\u00e9cembre\u202f2023. 2. Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31\u202fmars\u202f2024 \u00e9tait de 138. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge de travail. 3. [&hellip;]<\/p>\n","protected":false},"author":67,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ep_exclude_from_search":false,"footnotes":""},"categories":[],"tags":[],"site-tools":[],"ppma_author":[1977],"class_list":["post-72614","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u202f022\u202f776\u202f$ pour l\u2019exercice clos le 31\u202fd\u00e9cembre\u202f2023. 2. Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31\u202fmars\u202f2024 \u00e9tait de 138. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge de travail. 3. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-23T19:50:54+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/remuneration-2023-24\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/remuneration-2023-24\\\/\",\"name\":\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2024-07-03T20:44:29+00:00\",\"dateModified\":\"2025-07-23T19:50:54+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/remuneration-2023-24\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","og_description":"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u202f022\u202f776\u202f$ pour l\u2019exercice clos le 31\u202fd\u00e9cembre\u202f2023. 2. Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31\u202fmars\u202f2024 \u00e9tait de 138. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge de travail. 3. [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-07-23T19:50:54+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/","name":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2024-07-03T20:44:29+00:00","dateModified":"2025-07-23T19:50:54+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/"]}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages\/72614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/comments?post=72614"}],"version-history":[{"count":3,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages\/72614\/revisions"}],"predecessor-version":[{"id":72645,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages\/72614\/revisions\/72645"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=72614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/categories?post=72614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/tags?post=72614"},{"taxonomy":"site-tools","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/site-tools?post=72614"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/ppma_author?post=72614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}